babette JMED Announces Three for Two Stock Split
ST. LOUIS--(BUSINESS WIRE)--July 14, 1999--Jones Pharma Inc. (Nasdaq:JMED) announced that the company's board of directors declared a three for two stock split, in the form of a 50 percent stock dividend, to shareholders of record July 26, 1999, to be distributed Aug. 6, 1999.
The board further increased the next quarterly cash dividend 7 percent, to .025 per share, to shareholders of record Sept. 15, 1999, payable Oct. 1, 1999. This follows a 17 percent dividend increase announced June 1, 1999, for a combined increase in dividend in 1999 of 24 percent.
Jones Pharma Inc., founded in 1981, is an emerging specialty pharmaceutical manufacturer and marketer with an uninterrupted 17-year history of record sales and profits. The company's strategy has been to build a portfolio of growing products through the acquisition of under-promoted, promotion sensitive FDA approved products from other pharmaceutical companies.
For further information, please contact Investor Relations: 314/576-6100.
--------------------------------------------------------------------------------
Contact:
Jones Pharma Inc., St. Louis
Lynn Horwitz, 314/576-6100
(www.jmedpharma.com)
|
